We are international
Donate
publications TEXT SIZE   
meeting highlights    back

Phase I/II Study of Revlimid + Melphalan/Prednisone (R-MP) for Newly Diagnosed Myeloma
By Antonio Palumbo, MD
12.17.06

Be the first to comment

 related articles